Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CETP | P11597 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | UBE2N | P61088 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 9/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 5/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9545095 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1147732 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL27358898 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL27645826 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL8682114 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL9137980 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1147850 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL4875812 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL1147869 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL15016341 | 1.00 | LMNA (0.42) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8716558-B2 | Method of altering glycosylation of proteins in response to nojirimycin glucuronide in a plant cell expressing glucuronidase | MARKER GENE TECHNOLOGIES, INC. (US) | 2014-05-06 | — | — | US | disclosed |
| EP-1600449-B1 | Process for producing an ester, acetal, ketal, ether or alkyl glycoside | KAO CORP (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-20060105915-A1 | Compositions and methods for targeted enzymatic release of cell regulatory compounds | MARKER GENE TECHNOLOGIES, INC. | 2006-05-18 | — | — | US | disclosed |
| EP-1600449-A1 | Process for producing an ester, acetal, ketal, ether or alkyl glycoside | Kao Corporation (JP) | 2005-11-30 | — | — | EP | disclosed |
| EP-0980869-B1 | ALUMINUM COMPOUNDS AND USE THEREOF | KAO CORP (JP) | 2005-06-08 | — | — | EP | disclosed |
| US-20040101932-A1 | Compositions and methods for targeted enzymatic release of cell regulatory compounds | MARKER GENE TECHNOLOGIES, INC. | 2004-05-27 | — | — | US | disclosed |
| US-6656917-B1 | Enzyme encoded by vector recognizes and binds to the inactive conjugate, and releases the bioactive compound from conjugation in an amount effective to enhance growth | MARKER GENE TECHNOLOGIES, INC. | 2003-12-02 | — | — | US | disclosed |
| US-6207845-B1 | ORGANOALUMINUM COMPOUND; ACID CATALYST | KAO CORPORATION (JP) | 2001-03-27 | — | — | US | disclosed |
| EP-0980869-A1 | ALUMINUM COMPOUNDS AND USE THEREOF | Kao Corporation (JP) | 2000-02-23 | — | — | EP | disclosed |
| US-5439944-A | Red blood cell substitute emulsions containing alkyl- or alkylglyucerophosphoryl choline surfactants and methods of use | HEMAGEN/PFC (US) | 1995-08-08 | — | — | US | disclosed |
| US-5439669-A | Stable physiologically acceptable emulsion of fluorochemical, water, surfactant | HEMAGEN/PFC (US) | 1995-08-08 | — | — | US | disclosed |
| EP-0663829-A1 | EMULSIONS CONTAINING ALKYL- OR ALKYLGYLCEROPHOSPHORYL CHOLINE SURFACTANTS AND METHODS OF USE | HEMAGEN/PFC (US) | 1995-07-26 | — | — | EP | disclosed |
| US-5304325-A | Emulsions of fluorochemical, water, surfactant; synthetic blood | HEMAGEN/PFC (US) | 1994-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040101932-A1 | Compositions and methods for targeted enzymatic release of cell regulatory compounds | GUSB, PREP, PEPD | LMNA 1080/4885CYP2D6 87/4885SPHK1 3857/4885 |
| US-20060105915-A1 | Compositions and methods for targeted enzymatic release of cell regulatory compounds | GUSB, PREP, PEPD | LMNA 1080/4885CYP2D6 87/4885SPHK1 3857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.